Evidence map›Paper›PMID 30306128›Full record

ArticleScience advances2018

Cross-talk among writers, readers, and erasers of m

Subbarayalu Panneerdoss, Vijay K Eedunuri, Pooja Yadav, Santosh Timilsina, Subapriya Rajamanickam, Suryavathi Viswanadhapalli, Nourhan Abdelfattah, Benjamin C Onyeagucha, Xiadong Cui, Zhao Lai and 6 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 218 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
218citing papers in PubMed, 1 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

218 citing papers in PubMed, 1 synthesis or guideline pooled it, 362 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. mInsects · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. mMolecules (Basel, Switzerland) · 2025
    Review
  13. Article
  14. Enhancer regulation in cancer: from epigenetics to mArchives of pharmacal research · 2025
    Review
  15. Article
  16. An mNature communications · 2025
    Article
  17. Article
  18. Article
  19. IGF2BP2: an mCellular & molecular biology letters · 2025
    Review
  20. The landscape of NNature genetics · 2025
    Article

158 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Subbarayalu PanneerdossDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0002-9028-7193
Vijay K EedunuriDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Pooja YadavDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Santosh TimilsinaDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Subapriya RajamanickamGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Suryavathi ViswanadhapalliDepartment of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Nourhan AbdelfattahDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0002-0556-0977
Benjamin C OnyeaguchaDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Xiadong CuiDepartment of Electrical and Computer Engineering, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0002-4762-6161
Zhao LaiGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Tabrez A MohammadGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0002-9553-7841
Yogesh K GuptaGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0001-6372-5007
Tim Hui-Ming HuangDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Yufei HuangDepartment of Electrical and Computer Engineering, University of Texas at San Antonio, San Antonio, TX 78249, USA.
Yidong ChenGreehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0001-6806-2185
Manjeet K RaoDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0001-7573-2677
The University of Texas Health Science Center at San Antonio · USThe University of Texas at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUL1TR001120 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CLARK, ROBERT A, HARGREAVES, KENNETH M · 2013 to 2017
$16.5M
Predicting Drug Resistance in Cancer Genomes by DMA Methylation ProfilingU54CA113001 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HUANG, TIM H.-M. · 2004 to 2014
$16.1M
Systems Analysis of Epigenomic Architecture in Cancer ProgressionU54CA217297 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HUANG, TIM H.-M., JIN, VICTOR · 2017 to 2021
$9.3M
Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBCR01CA179120 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RAO, MANJEET KUMAR, VADLAMUDI, RATNA K · 2015 to 2019
$1.7M
Collaborative Research:Graphical models for characterizing global RNA methylationR01GM113245 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI HUANG, YUFEI · 2014 to 2016
$1.1M
High Throughput DNA Sequencer: Illumina HiSeq 3000 SequencerS10OD021805 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAI, ZHAO · 2016 to 2016
$600k
NCATS NIH HHS UL1 TR001120NCI NIH HHS P30 CA054174NCI NIH HHS R01 CA179120NCI NIH HHS T32 CA148724NCI NIH HHS U54 CA113001NCI NIH HHS U54 CA217297NIGMS NIH HHS R01 GM113245NIH HHS S10 OD021805
6 · The paper itself

Abstract

The importance of RNA methylation in biological processes is an emerging focus of investigation. We report that altering m

Indexed as

AdenosineAlkB Homolog 5, RNA DemethylaseAnimalsCell CycleCell Line, TumorELAV-Like Protein 1Feedback, PhysiologicalFemaleGene Expression Regulation, NeoplasticHumansMethyltransferasesMice, NudeNeoplasmsNeovascularization, PathologicRNA-Binding ProteinsTumor HypoxiaAdenosineALKBH5 protein, humanAlkB Homolog 5, RNA DemethylaseELAVL1 protein, humanELAV-Like Protein 1MethyltransferasesMETTL14 protein, humanN-methyladenosineRNA-Binding ProteinsYTHDF3 protein, human

Identifiers

PMID30306128
PMCPMC6170038
OpenAlexW2895593282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.